Folgen
Jaime E. Hallak
Jaime E. Hallak
Bestätigte E-Mail-Adresse bei fmrp.usp.br
Titel
Zitiert von
Zitiert von
Jahr
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
9412017
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients
MM Bergamaschi, RHC Queiroz, MHN Chagas, DCG De Oliveira, ...
Neuropsychopharmacology 36 (6), 1219-1226, 2011
9242011
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
F Palhano-Fontes, D Barreto, H Onias, KC Andrade, MM Novaes, ...
Psychological medicine 49 (4), 655-663, 2019
7872019
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
JAS Crippa, GN Derenusson, TB Ferrari, L Wichert-Ana, FLS Duran, ...
Journal of psychopharmacology 25 (1), 121-130, 2011
6472011
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
AW Zuardi, JAS Crippa, JEC Hallak, FA Moreira, FS Guimarães
Brazilian journal of medical and biological research 39, 421-429, 2006
5882006
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
FL Osório, RF Sanches, LR Macedo, RG Dos Santos, JP Maia-de-Oliveira, ...
Brazilian Journal of Psychiatry 37, 13-20, 2015
5792015
Síndrome de burnout ou estafa profissional e os transtornos psiquiátricos
TR Trigo, CT Teng, JEC Hallak
Archives of Clinical Psychiatry (São Paulo) 34, 223-233, 2007
5502007
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study
RF Sanches, F de Lima Osório, RG Dos Santos, LRH Macedo, ...
Journal of clinical psychopharmacology 36 (1), 77-81, 2016
5252016
The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network
F Palhano-Fontes, KC Andrade, LF Tofoli, AC Santos, JAS Crippa, ...
PloS one 10 (2), e0118143, 2015
4672015
Cannabidiol for the treatment of psychosis in Parkinson’s disease
AW Zuardi, JAS Crippa, JEC Hallak, JP Pinto, MHN Chagas, ...
Journal of Psychopharmacology 23 (8), 979-983, 2009
4422009
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial
MHN Chagas, AW Zuardi, V Tumas, MA Pena-Pereira, ET Sobreira, ...
Journal of Psychopharmacology 28 (11), 1088-1098, 2014
4132014
Confiabilidade da" Entrevista Clínica Estruturada para o DSM-IV-Versão Clínica" traduzida para o português
CM Del-Ben, JAA Vilela, JAS Crippa, JEC Hallak, CM Labate, AW Zuardi
Brazilian Journal of Psychiatry 23, 156-159, 2001
3802001
Neuroimaging in social anxiety disorder: a systematic review of the literature
MC Freitas-Ferrari, JEC Hallak, C Trzesniak, A Santos Filho, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 34 (4), 565-580, 2010
3662010
Effects of cannabidiol (CBD) on regional cerebral blood flow
JAS Crippa, AW Zuardi, GEJ Garrido, L Wichert-Ana, R Guarnieri, ...
Neuropsychopharmacology 29 (2), 417-426, 2004
3662004
Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco–magnetic resonance imaging study
JFW Deakin, J Lees, S McKie, JEC Hallak, SR Williams, SM Dursun
Archives of general psychiatry 65 (2), 154-164, 2008
3612008
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the …
RG Dos Santos, FL Osório, JAS Crippa, J Riba, AW Zuardi, JEC Hallak
Therapeutic advances in psychopharmacology 6 (3), 193-213, 2016
3412016
Use of the Fonseca's questionnaire to assess the prevalence and severity of temporomandibular disorders in Brazilian dental undergraduates
K Nomura, M Vitti, AS Oliveira, TC Chaves, M Semprini, S Siéssere, ...
Brazilian dental journal 18, 163-167, 2007
3342007
Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
IB Chaudhry, J Hallak, N Husain, F Minhas, J Stirling, P Richardson, ...
Journal of psychopharmacology 26 (9), 1185-1193, 2012
3302012
Age and gender influence on maximal bite force and masticatory muscles thickness
M Palinkas, MSP Nassar, FA Cecílio, S Siéssere, M Semprini, ...
Archives of oral biology 55 (10), 797-802, 2010
3232010
Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion
DB De Araujo, S Ribeiro, GA Cecchi, FM Carvalho, TA Sanchez, JP Pinto, ...
Human brain mapping 33 (11), 2550-2560, 2012
2972012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20